Study title: An open evaluation of itraconazole oral solution in paediatric patients undergoing treatment for haematological malignancy or solid tumour. Safety findings.
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Bacterial Infections and Mycoses | |||||
| Brands: Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: ITRACONAZOLE | |||||
| ATC code: J02AC02 | |||||
| Document link: LMD129189_Interventional_Itraconazole.xls | |||||
| Document date: 2011-09-30 | |||||
| Study number: LMD129189 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |